In rats, cannabis altered liver markers; vitamin C helped at lower doses
Mitigating Cannabis sativa-induced liver toxicity in male Wistar rats: protective role of vitamin C.
AI Summary
This animal study investigated whether oral Cannabis sativa exposure alters liver function in male Wistar rats and whether vitamin C offers protection. Rats received 2, 4, or 6 mg/kg of Cannabis sativa, vitamin C, or both for three weeks, with untreated animals serving as controls. The abstract does not report the number of animals studied.
Compared with controls, all tested cannabis doses significantly (p<0.05) increased several liver-related biomarkers, including gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and lactate dehydrogenase (LDH), while decreasing albumin and induced protein. These changes were greater at 6 mg/kg than at the lower doses. Co-administration of vitamin C reduced the biomarker changes at 2 and 4 mg/kg, but the abstract does not show that it protected against the highest exposure. Because this was a short-term rat study based on biomarkers, it cannot establish liver toxicity or vitamin C treatment effectiveness in humans; this is an abstract-based summary, not a full-text review.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Inflammation research papers you might find interesting.
Review links lifestyle and the ECS in MS, but finds no proven…
In septic rats, lenabasum reduced lung injury markers over 24 hours
Endocannabinoid levels differed in RA and tracked disease activity in women
Explore More Research
Stay informed about the latest cannabis science.